CRESCENT PHARMA LIMITED — Gliclazide Importer Profile
Pharmaceutical Importer · #15 buyer for Gliclazide · $1.2M import value · 54 shipments · UNITED KINGDOM · DGFT Verified
CRESCENT PHARMA LIMITED is the #15 importer of Gliclazide from India with $1.2M in import value and 54 verified shipments. CRESCENT PHARMA LIMITED holds a 0.4% market share in Gliclazide imports based in UNITED KINGDOM. The company sources from 1 verified supplier across 35 formulations shipped to 1 country. Overall, CRESCENT PHARMA LIMITED imports 6 pharmaceutical products worth $11.8M across 5 therapeutic categories.
CRESCENT PHARMA LIMITED — Gliclazide Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Gliclazide to CRESCENT PHARMA LIMITED?
Verified from 54 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| UNISON PHARMACEUTICALS PRIVATE LIMITED | $1.2M | 54 | 100.0% |
CRESCENT PHARMA LIMITED sources Gliclazide from 1 verified Indian supplier based on 54 customs records. The primary supplier is UNISON PHARMACEUTICALS PRIVATE LIMITED accounting for 100.0% of imports.
How Does CRESCENT PHARMA LIMITED Compare to Nearest Gliclazide Importers?
Buyers ranked immediately above and below #15 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | TORRENT DO BRASIL LIMITEDA | BRAZIL | $1.6M | 58 | $27.9K |
| 11 | SUN PHARMA CANADA INC. | CANADA | $1.4M | 27 | $50.0K |
| 15 | CRESCENT PHARMA LIMITED ★ | UNITED KINGDOM | $1.2M | 54 | $22.2K |
| 1 | MYLAN HUNGARY KFT, | HUNGARY | $1.1M | 21 | $50.0K |
| 2 | DANANG PHARMACEUTICAL MEDICAL EQUIP | VIETNAM | $1.1M | 21 | $50.0K |
CRESCENT PHARMA LIMITED ranks #15 among 643 Gliclazide importers from India. Average shipment value of $22.2K compared to the market average of $40.7K. The closest competitors by value are TORRENT DO BRASIL LIMITEDA and SUN PHARMA CANADA INC..
Where Does CRESCENT PHARMA LIMITED Import Gliclazide To?
Destination countries from 54 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $1.2M | 54 | 100.0% |
CRESCENT PHARMA LIMITED imports Gliclazide to 1 country. The primary destination is UNITED KINGDOM receiving 100.0% of shipments worth $1.2M.
What Gliclazide Formulations Does CRESCENT PHARMA LIMITED Import?
| Formulation | Value | Shipments |
|---|---|---|
| GLICLAZIDE 80 MG TABLETS (GLICLAZIDE)(2X14T)BL(GLICLAZIDE)B.NO.2330948 TO 2330952,2330997,2331022,2331023 AS PER INVOICENOS | $108.2K | 3 |
| GLICLAZIDE 80 MG TABLETS GLICLAZIDE 2 | $94.6K | 2 |
| GLICLAZIDE 80 MG TABLETS GLICLAZIDE BA | $94.5K | 2 |
| GLICLAZIDE 80 MG TABLETS (GLICLAZIDE) 2X 14 B.NO.: 2430233 TO 2430236 AS PER INVOICE | $54.8K | 3 |
| GLICLAZIDE 80 MG TABLETS (GLICLAZIDE) ( | $50.0K | 1 |
| GLICLAZIDE 80 MG TABLETS(2X14T)BL (GLICLAZIDE) B.No.: 2430246 2430309 2430310& 2430398 AS PER INVOICE | $50.0K | 1 |
| GLICLAZIDE 80 MG TABLETS (2X14T) BL(GLICLAZIDE)(1 NOS=1 PACK)(B. NO.2530089,2530090,2530091,2530092 & 2530136) (AS INV) | $50.0K | 1 |
| GLICLAZIDE 40 MG TABLETS(2x14T)BL (GLICLAZIDE) B.No.: 2530225,2530226 & 2530227MFG. DT: 02/2025 EXP. DT: 01/2027 (AS PE | $50.0K | 1 |
| GLICLAZIDE 80 MG TABLETS GLICLAZIDE -2X14 B.NO : 2330770 2330771 2330772 | $45.9K | 1 |
| GLICLAZIDE 80 MG TABLETS 2X14T BL GLICLAZIDE B No 2530507 2530512 2530513 DETAILS AS PER INVOICE | $32.6K | 1 |
CRESCENT PHARMA LIMITED imports 35 distinct Gliclazide formulations from India. The top formulation is GLICLAZIDE 80 MG TABLETS (GLICLAZIDE)(2X14T)BL(GLICLAZIDE)B. with 3 shipments worth $108.2K.
Regulatory Requirements: Importing Gliclazide into United Kingdom
What CRESCENT PHARMA LIMITED and other importers must comply with to import Gliclazide from India
Regulatory Authority
Medicines and Healthcare products Regulatory Agency (MHRA)
Approval Process for Generic Gliclazide
Marketing Authorisation via national procedure or Mutual Recognition. Post-Brexit, separate UK MA required independent of EU approval.
Typical timeline: 12–15 months for national procedure
GMP Requirements
UK GMP compliance; MHRA GMP inspection of manufacturing site
Import Licence & Documentation
Manufacturer/Importer Authorisation (MIA) from MHRA; Qualified Person release required
Labeling & Packaging
UK-specific labeling; English language PIL; UK Marketing Authorisation number
Note: Post-Brexit, EU GMP certificates no longer automatically valid — separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available MHRA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with MHRA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Gliclazide from India and How Much Does CRESCENT PHARMA LIMITED Import?
India exported $26.2M worth of Gliclazide through 3,830 shipments from 238 suppliers to 109 countries, serving 643 buyers globally. CRESCENT PHARMA LIMITED imports $1.2M of this total, accounting for 0.4% of India's Gliclazide exports with 54 shipments from UNITED KINGDOM. This is verified from 54 customs shipment records covering 35 distinct formulations.
What Is the Average Order Value for CRESCENT PHARMA LIMITED's Gliclazide Imports?
CRESCENT PHARMA LIMITED's average Gliclazide order value is $21.7K per consignment, based on 54 shipments totaling $1.2M. CRESCENT PHARMA LIMITED is based in UNITED KINGDOM and ranks #15 among all Gliclazide importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Gliclazide to CRESCENT PHARMA LIMITED?
CRESCENT PHARMA LIMITED sources Gliclazide from 1 verified Indian supplier: UNISON PHARMACEUTICALS PRIVATE LIMITED ($1.2M, 100.0%). This is based on 54 customs records.
How Does CRESCENT PHARMA LIMITED Compare to Other Gliclazide Importers?
CRESCENT PHARMA LIMITED ranks #15 among 643 Gliclazide importers from India with a 0.4% market share. The top 3 importers are TORRENT DO BRASIL LTDA ($6.5M), MEDREICH PLC ($3.1M), M/S. RANBAXY FARMACEUTICA LTDA : ($2.4M). CRESCENT PHARMA LIMITED processed 54 shipments from UNITED KINGDOM.
About CRESCENT PHARMA LIMITED
CRESCENT PHARMA LIMITED imports 6 products worth $11.8M. Beyond Gliclazide, top products include Ramipril, Levothyroxine, Terbinafine, Diazepam, Clonazepam. View the complete CRESCENT PHARMA LIMITED profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Gliclazide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Gliclazide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: CRESCENT PHARMA LIMITED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as CRESCENT PHARMA LIMITED's capped import value divided by total capped export value for Gliclazide across all Indian exporters.
- 5.Verified Records: This page is backed by 54 individual customs records matching CRESCENT PHARMA LIMITED importing Gliclazide, covering 35 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 109+ countries, 643+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Gliclazide Import Data for CRESCENT PHARMA LIMITED
Access order-level details, pricing data, supplier connections, and competitive analysis for CRESCENT PHARMA LIMITED's Gliclazide imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
CRESCENT PHARMA LIMITED
Full Company Profile →
6 products · $11.8M total trade · 5 categories
CRESCENT PHARMA LIMITED × Gliclazide
Verified from customs records
Company Overview
Top Products by CRESCENT PHARMA LIMITED
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for CRESCENT PHARMA LIMITED.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Gliclazide. For current order-level data, contact TransData Nexus.